公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, W; Chang, TT; Yang, HI ; Peng, CY; Su, CW; Su, TH; Hu, TH; Yu, ML; Yang, HC; Wu, JC | Hepatology international 15, 1421-1430 |